MétaCan
Menu
← Back to cohort
Record W4417345728 · doi:10.64898/2025.12.11.25337743

Helping Underdeveloped Lungs with Cells (HULC)-2 Mesenchymal Stromal Cells in extreme preterm infants at risk of developing Bronchopulmonary Dysplasia – A Phase 2 Multi-Centre Double Blind Randomized Controlled Trial Study Protocol

2025· article· W4417345728 on OpenAlexafffundabout
Laurent Renesme, Emanuela Ferretti, Chantal Horth, Liam Da Sylva, Viviane Olson, Chanèle Cyr-Depauw, Daniel Freund, Mario Ruediger, Marius Alexander Meobius, S. Hodgins, Saad Khan, David W. Courtman, Dean Fergusson, Bernard Thébaud

Bibliographic record

VenuemedRxiv · 2025
Typearticle
Language
FieldMedicine
TopicNeonatal Respiratory Health Research
Canadian institutionsChildren's Hospital of Eastern OntarioOttawa Hospital
FundersCanadian Institutes of Health ResearchStem Cell Network
KeywordsBronchopulmonary dysplasiaRandomized controlled trialMesenchymal stem cellUmbilical cordGestational ageMechanical ventilationClinical trial

Abstract

fetched live from OpenAlex

Abstract Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants, with long-term respiratory and neurodevelopmental consequences. Despite advances in neonatal care, effective therapies to prevent BPD are lacking. Mesenchymal stromal cells (MSC), particularly those derived from umbilical cord (UC-MSC), offer promise due to their pleiotropic effects. Preclinical and early-phase clinical studies have demonstrated safety and potential efficacy of MSC in neonatal lung injury. The HULC-2 trial aims to evaluate whether multiple intravenous doses of human allogenic UC-MSC can reduce mechanical ventilation duration and improve the respiratory outcome in ELGA infants at high risk of developing BPD. Methods and Analysis HULC-2 is a multicenter, double-blind, randomized controlled Phase II trial conducted in Canadian Neonatal Intensive Care Units. ELGA infants (gestational age <28 weeks) who remain ventilator-dependent between 4–14 days of life will be randomized to receive either three weekly intravenous doses of UC-MSC (10×10^6 cells/kg/dose) or a sham procedure. The primary outcome is ventilation-free days (VFDs) at 120 days post-randomization, accounting for mortality. Secondary outcomes include cell administration safety, respiratory and neurodevelopmental outcomes, and complications of prematurity. A total of 168 participants will be enrolled to detect a clinically meaningful difference in VFDs. Ethics and Dissemination Ethics approval has been obtained, and the trial is registered on ClinicalTrials.gov. Results will be disseminated via peer-reviewed publications, conferences, and public engagement platforms. Parent partners are actively involved in study design and dissemination to ensure relevance and transparency. Strengths and limitations of this study Ventilation-free day (VFD) is a clinically relevant primary outcome compared to BPD, as prolonged mechanical ventilation in preterm infants is directly associated with increased risks of mortality, neurodevelopmental impairment, and other complications, making VFDs a more sensitive and meaningful measure of both survival and recovery Use of a multiple-dose regimen and fresh cell product to optimize the cell’s therapeutic potential Cell product was tested in a large animal model of BPD Parents’ involvement in the trial design and development to deliver meaningful research that benefits patients and increase study acceptance among parents. A sham procedure was chosen over a placebo based on parent feedback, which increased the risk of unblinding, but strategies to mitigate that risk were developed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.019
Threshold uncertainty score0.064

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.006
Meta-epidemiology (narrow)0.0040.001
Meta-epidemiology (broad)0.0060.003
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0020.001
Open science0.0020.001
Research integrity0.0040.003
Insufficient payload (model declined to judge)0.0190.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.083
GPT teacher head0.398
Teacher spread0.315 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes3
Has abstractyes

Explore more

Same venuemedRxiv→Same topicNeonatal Respiratory Health Research→French-language works237,207→